AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04351321 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Totally Laparoscopic Total Gastrectomy
Description: Totally laparoscopic total gastrectomy will be performed in patients with gastric or esophagogastric junction adenocarcinoma of preoperative clinical stage I (T1N0M0, T1N1M0, T2N0M0) with D1+/D2 lymph node dissection.
Study NCT04351321 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopy-Assisted Total Gastrectomy
Description: Laparoscopy-Assisted Total Gastrectomy will be performed in patients with gastric or esophagogastric junction adenocarcinoma of preoperative clinical stage I (T1N0M0, T1N1M0, T2N0M0) with D1+/D2 lymph node dissection.
Study NCT05689957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block using intravenous rocuronium induction at 1.2mg/kg and maintainance of 8-12mcg/kg/min for deep neuromuscular block
Description: both arm are using low pressure pneumoperitoneum in laparoscopic surgery, moderate and deep neuromuscular block are monitor with neuromuscular monitoring. if surgical condition is inadequate, surgeon are allowed to increase intraabdominal pressure as per standard care
Study NCT05689957 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Deep neuromuscular block using intravenous rocuronium induction at 1.2mg/kg and maintainance of 8-12mcg/kg/min for deep neuromuscular block
Description: both arm are using low pressure pneumoperitoneum in laparoscopic surgery, moderate and deep neuromuscular block are monitor with neuromuscular monitoring. if surgical condition is inadequate, surgeon are allowed to increase intraabdominal pressure as per standard care
Study NCT01675466 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: early laparoscopy
Description: Laparoscopy under performed by the surgeon on duty or his/her deputy. The aim is to achieve this within 12 hours of randomisation. This will be performed under general anaesthetic and involve the necessary drugs. The procedure will require laparoscopy instruments. There will be a umbilical port which will be 10mm in size and one 5mm port below this. If pathology is found, a further port will be needed to perform treatment.
Study NCT01675466 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General anaesthesia
Study NCT01675466 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic instruments
Study NCT03238612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FFA, clarithromycin, oseltamivir
Description: 2-day course of triple combination of clarithromycin 500mg, flufenamic acid 200mg and oseltamivir 75mg twice daily followed by oseltamivir 75mg twice daily for 3 days
Study NCT03238612 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oseltamivir alone
Description: 2-day course of oseltamivir 75mg plus placebo capsules twice daily followed by oseltamivir 75mg twice daily for 3 days as control
Study NCT03231566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: See arm/group description
Study NCT03231566 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pain Neuroscience Education
Description: See arm/group description
Study NCT02566434 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: methionine
Description: 4 weeks intervention and 2 to 4 weeks washout in healthy volunteers with free methionine at 10 mg/kg body weight/day (=requirement), 25 mg/kg body weight/day, 50 mg/kg body weight/day and 100 mg/kg body weight/day.
Study NCT02501473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G100
Description: GLA is a fully synthetic toll-like receptor-4 (TLR4) agonist
Study NCT03090711 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham Transcranial Magnetic Stimulation (TMS)
Description: Sham coil will be used to exclude possible nonspecific effects of the TMS. The sham coil is shielded i.e., the magnetic field output is weakened and therefore insufficiently powerful to stimulate the cortex.
Study NCT03090711 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham Transcranial Alternating Current Stimulation (tACS)
Description: Sham stimulation will be used to exclude possible nonspecific effects of the tACS. Sham tACS stimulation will involve actual stimulation for the first 30 seconds of the ramp-up period (stimulation power is gradually increased until its final level), and then immediately gradually decreased until zero (without the intermediate 4 minutes of actual stimulation). This procedure will be repeated 5 times every 6 minutes and shall induce similar cutaneous sensations as real stimulation.
Study NCT02050802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg
Study NCT02050802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan 30 mg
Study NCT02050802 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02987361 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: DC-STIMULATOR PLUS
Description: 2mA for 20minutes a day, 5 days per weeks, totally 2 weeks
Study NCT02987361 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DC-STIMULATOR PLUS
Description: 2mA for 20minutes a day, 5 days per weeks, totally 2 weeks
Study NCT02645643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education of medical humanities
Description: The medical students in the intervention group would gain education about the medical humanities, but not the control group.
Study NCT00742989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OLT maneuver
Description: direct myofascial release for the thoracic inlet for 30 seconds, supine rib raising for 1 minute on each side of the body, thoracic pumping for one minute, thoracic vacuum for 30 seconds, doming of the abdominal diaphragm for 30 seconds, abdominal pumping for 1 minute, pedal pumping for 1 minute, a second thoracic pump for 1 minute, a second thoracic vacuum for 30 seconds, and a final direct myofascial release for the thoracic inlet lasting 30 seconds
Study NCT00742989 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham OLT
Description: Therapeutic massage performed
Study NCT01858545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MatriStem
Description: MatriStem MicroMatrix and MatriStem Wound Matrix
Study NCT01858545 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cellular Dermal Replacement Tissue
Description: Cellular Dermal Replacement Tissue
Study NCT03549208 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LBVE01
Description: Multivalent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh
Study NCT03549208 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LBVE02
Description: Multivalent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh
Study NCT03549208 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar13
Description: 13-valent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh
Study NCT03854526 — intervention group
Intervention type: OTHER
Intervention: Evaluation of the quality of direct and indirect partial dental coronal restorations in adults
Description: The medical and dental anamnesis are registered. In addition to the medical history questionnaire, the patient completes the self-assessment questionnaire on oral health. Then, a complete and intra-oral clinical examination is performed. The collection of clinical data is done on the dentist's chair. All data are included in the e-CRF.~All radiographic procedures will be performed according to national guidelines. If the investigator deems it clinically necessary, a panoramic X-ray will be taken and stored in the patient's HER system. Periapical radiographs (using a parallelogram technique with a radiographic film holder) will be taken for teeth with periapical radiolucency on panoramic X-ray, or with defective coronal restoration, or when the clinician needs more information for diagnosis or planning.
Study NCT02734771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin
Study NCT02734771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Study NCT02734771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02734771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Study NCT02734771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Study NCT02803177 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BMC2012
Study NCT02803177 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: beta-TCP Chronos® Synthes
Study NCT00885586 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham-laser acupuncture
Description: Laser irradiation is faked, approaching a non-functioning laser pen.
Study NCT02501473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: PD-1 Inhibitor
Study NCT02501473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab (anti-CD20 antibody)
Study NCT04369521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low free sugar diet
Description: low free sugar diet with nutrition and exercise recommendation
Study NCT03157778 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Obese men
Description: Biological measures before, just before, and after lunch, in obese men
Study NCT03157778 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Normal-weight men
Description: Biological measures before, just before, and after lunch, in normal-weight men.
Study NCT03630172 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Using a thin, filiform needle to penetrate a muscle and its trigger point to produce a local twitch response
Study NCT03630172 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Dry needling
Description: Using a thin, filiform needle to penetrate a muscle and its trigger point to produce a local twitch response
Study NCT06040372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB64640
Description: The investigational product (IP) LB54640 is provided 5 mg, 25 mg and 200 mg strengths.
Study NCT06040372 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is provided as a matching placebo
Study NCT02524795 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hiomega-3 supplement of Naturalis® company -
Description: Patients (N=22) were seen at baseline (T0) and at week 12 (T1) for clinical, laboratory and nutritional assessment, and were contacted by telephone in week 6 to check on compliance and any adverse events. Patients received, throughout 12 weeks, two tablets per day of omega-3 fatty acids (540mg of EPA and DHA of 100mg; Hiomega-3 supplement of Naturalis® company - registered in the National Health Department number 4.1480.0006.001-4). All participants were instructed not to take omega-3 rich foods during the study period.
Study NCT02597075 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard therapy + physical activity program
Study NCT02597075 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard therapy
Study NCT04287244 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Spinal Direct Current Stimulation
Description: tSDCS will be administered through a pair of conductive rubber electrodes covered by saline soaked sponges (35 cm2). The current will be delivered continuously at 2 mA for 30 min through a battery-driven constant-current stimulator (Sooma Oy, Helsinki, Finland).
Study NCT04287244 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous Spinal Direct Current Stimulation
Description: tSDCS will be administered through a pair of conductive rubber electrodes covered by saline soaked sponges (35 cm2). The current will be delivered continuously at 2 mA for 30 min through a battery-driven constant-current stimulator (Sooma Oy, Helsinki, Finland).
Study NCT02156596 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV NSAI
Description: 100 mg of ketoprofen in 50 ml volume given in 30 minutes by IV root
Study NCT02156596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NM
Description: 3 nebulisations of 5 mg morphine chlorhydrate each given over 30 minutes (10 minutes per nebulisation)
Study NCT02156596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Serum Saline
Description: 50 ml of SS is given by IV root over 30 minutes
Study NCT02156596 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nebulised Serum Saline
Description: 3 nebulisations of 5ml SS each are given over 30 minutes
Study NCT00885586 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gabapentine
Description: Patients in this arm are treated individually with gabapentine 900 mg/d - 3600 mg/d, according to the recommended scheme given by the manufacturer
Study NCT03291808 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Description: This 6-month intervention will include restricted calorie intake and increased physical activity. Key behavioral strategies to facilitate changes in dietary habits and activity patterns will be introduced, promoted and reinforced throughout the program. Weekly group meetings in a synchronous chat (i.e., in real time) led by a facilitator will be the venue for the group process. Extensive web-based resources to support behavior changes will be offered. Group chat sessions will meet online weekly for 6 months.
Study NCT03878966 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inserting polymer free drug eluting stent in the coronary arteries
Description: • Early invasive strategy with percutaneous coronary intervention will be done for the patients presenting with NST ACS who meet the inclusion criteria using Polymer-free drug eluting stents instead of the polymer-permanent drug eluting stents .
Study NCT03197649 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser phototherapy treatment
Description: Laser phototherapy treatment administered in OR
Study NCT03233646 — intervention group
Intervention type: DEVICE
Intervention: Retinal and Choroidal Imaging
Description: Non-invasive OCT, OCTA, and UWF fundus photography of retina
Study NCT02225301 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: iLook Out for Child Abuse
Description: The online learning module is an interactive, multi-media, self-paced intervention.
Study NCT00885586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: The needle acupuncture technique used in this trial is performed according the traditional way (TCM) using expendable needles.
Study NCT01847066 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Erbium 2940 plus cosmetics plus Impact
Description: Laser used in all arms
Study NCT01847066 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Erbium 2940 plus cosmetics
Description: laser
Study NCT01709422 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol is the sedative drug used as an additional sedation to one of the study arm.
Study NCT01709422 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Midazolam is one of the two conventional sedative drugs included in both arms.
Study NCT01709422 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meperidine
Description: Meperidine is one of the two conventional sedative drugs included in both arms.
Study NCT00877786 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Group Therapy
Description: Cognitive behavioral therapy (CBT) is a form of psychotherapy that addresses the links between thoughts, emotions and behaviors.
Study NCT00770497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Description: Pioglitazone 15 mg, tablets, orally, once daily and ramipril placebo-matching tablets, orally, once daily for two weeks; increased to:~Pioglitazone 30 mg, tablets, orally, once daily and ramipril placebo-matching tablets, orally, once daily for up to 10 weeks.
Study NCT00770497 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pioglitazone and ramipril
Description: Pioglitazone 15 mg, tablets, orally, once daily and ramipril 2.5 mg, tablets, orally, once daily for two weeks; increased to:~Pioglitazone 30 mg, tablets, orally, once daily and ramipril 5 mg, tablets, orally, once daily for up to 10 weeks.
Study NCT00770497 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ramipril
Description: Pioglitazone placebo-matching tablets, orally, once daily and ramipril 2.5 mg, tablets, orally, once daily for two weeks; increased to:~Pioglitazone placebo-matching tablets, orally, once daily and ramipril 5 mg, tablets, orally, once daily for up to 10 weeks.
Study NCT05021302 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NOVAMAG NT-60
Description: The Electromagnetic stimulation consists of 15 sessions with 20 minutes duration and three times a week. The total length of therapy is five weeks.
Study NCT05021302 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Kegel Exercises
Description: Self-supporting pelvic floor muscle strengthening exercises performed at home by contracting and relaxing quickly (2 seconds of contraction and 4 seconds of rest), followed by a slow contraction (contraction for 5 seconds, and rest for 10 seconds with five times each) five sets per day. The average length of exercise for each session is 2 minutes, with total exercise per day is 50 times. Thus, the total length of exercise is 10 minutes. It was done every day for eight weeks.
Study NCT05771441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neck stabilization exercise (nse)
Description: neck stabilization exercise (nse)- exercise
Study NCT05771441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NSE + HOT PACK THERAPY
Description: NSE + HOT PACK THERAPY- exercise plus heat therapy
Study NCT05771441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NSE + infrared therapy
Description: NSE + infrared therapy- exercise plus heat therapy
Study NCT05771441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NSE + ultrasound therapy
Description: NSE + ultrasound therapy exercise plus heat therapy
Study NCT03771131 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training
Description: Weekly sessions of multi-domain cognitive training, each lasting around one hour for an overall duration of the training of 3 months (13 sessions)
Study NCT00737854 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical resection
Description: 20 patients with OLP will be selected for this study. Before this routine treatment modalities had been attempted. Removal of possible triggering drug was also considered. Local ethical committee approval will be obtained before the trial starts. Surgical procedure includes: removal of the tissue up to submucosa (containing antigenic properties that caused OLP). A specimen will be sent for histopathologic analysis. The graft sliced from healthy mucosa also up to submucosa. Then the graft trimmed on a gauze soaked in saline and adapted to recipient site. The graft was sutured in position. Checking will be done after 1 week and every two months up to 1 year. Punch biopsy will be done in 1 year after surgery for histopathologic investigations.
Study NCT04222634 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Radiotherapy (SBRT) and/or surgery (metastasectomy)
Description: Metastasis-directed therapy (surgery and/or radiotherapy) as treatment for oligoprogressive lesions
Study NCT01369641 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Insertion of Pressure Equalization (PE) Tubes
Description: If the subject consents to participate in the study, a separate consent for insertion of pressure equalization (PE) tubes will be obtained. The PE tubes will then be inserted into the posterior inferior quadrant of the tympanic membrane in the office under topical anesthesia.
Study NCT01369641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insertion of Pressure Equalization (PE) Tubes
Description: If the subject consents to participate in the study, a separate consent for insertion of pressure equalization (PE) tubes will be obtained. The PE tubes will then be inserted into the posterior inferior quadrant of the tympanic membrane in the office under topical anesthesia.
Study NCT01369641 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate (STS)
Description: Drops of STS will be added to the experimental ear only prior to initial cisplatin infusion.
Study NCT01369641 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline (Placebo)
Description: Drops of balanced saline solution will be added to the placebo comparator ear prior to initial cisplatin infusion.
Study NCT01369641 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin chemotherapy infusion in the dose range of 80-120mg/m2
Study NCT01369641 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin chemotherapy infusion in the dose range of 80-120mg/m2
Study NCT04883125 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pioglitazone 15mg
Description: pioglitazone (7.5-30 mg) once daily plus imatinib 400 mg 6 months